Feb 28, 2022 / 12:30PM GMT
Sonya Ghobrial -
Good morning and good afternoon. I'm Sonya Ghobrial, Head of Investor Relations for GSK Consumer Healthcare. Thank you for joining us today for the GSK Capital Markets Day to introduce you to Haleon. The team and I are looking forward to sharing more information on the company ahead of its demerger from GSK in July this year, after which we'll be operating as a separately listed independent company.
We have a full agenda today, featuring a number of our designated executive leadership team as well as the GSK CEO. However, before we start, I'd like to mention a couple of housekeeping details.
Our presentations will last for just over 3 hours in total, and there'll be time for 2 short refreshment breaks based at appropriate intervals between these presentations. A copy of today's agenda should be visible on the Investors section of gsk.com. There'll also be a Q&A session at the end of the presentations, ahead of which there'll be a short 5-minute break to allow those who want to dial in to ask questions. I'll be back a bit later to share this number for those who are listening
GlaxoSmithKline PLC and HALEON PLC Consumer Healthcare Capital Markets Day Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot